Development Trends: Peripheral Arterial Disease (PAD) Therapeutics Market By Key Vendors: Athersys, Merck & Co 2019-2025

Qyresearchreports include new market research report Peripheral Arterial Disease (PAD) Therapeutics to its huge collection of research reports.

Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke.[3] Up to 50% of cases of PAD are without symptoms.

In 2018, the global Peripheral Arterial Disease (PAD) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Peripheral Arterial Disease (PAD) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peripheral Arterial Disease (PAD) Therapeutics development in United States, Europe and China.

Get Free Sample Report of the Research Study at: https://www.qyresearchreports.com/sample/sample.php?rep_id=2041230&type=S

The key players covered in this study
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
AnGes MG, Inc. (Japan)
Athersys, Inc. (US)
Betagenon AB (Sweden)
miRagen Therapeutics, Inc. (US)
...

The study objectives of this report are:

To analyze global Peripheral Arterial Disease (PAD) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Peripheral Arterial Disease (PAD) Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-Platelet Drugs
1.4.3 Dual Antiplatelet Therapy Drugs
1.4.4 Others
1.5 Market by Application
1.5.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size
2.2 Peripheral Arterial Disease (PAD) Therapeutics Growth Trends by Regions
2.2.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions (2014-2025)
2.2.2 Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Manufacturers
3.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Manufacturers (2014-2018)
3.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Manufacturers (2014-2018)
3.1.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players Head office and Area Served
3.3 Key Players Peripheral Arterial Disease (PAD) Therapeutics Product/Solution/Service
...

List of Tables and Figures

Table Peripheral Arterial Disease (PAD) Therapeutics Key Market Segments
Table Key Players Peripheral Arterial Disease (PAD) Therapeutics Covered
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type 2014-2025
Figure Anti-Platelet Drugs Figures
Table Key Players of Anti-Platelet Drugs
Figure Dual Antiplatelet Therapy Drugs Figures
Table Key Players of Dual Antiplatelet Therapy Drugs
Figure Others Figures
Table Key Players of Others
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Peripheral Arterial Disease (PAD) Therapeutics Report Years Considered
Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size 2014-2025 (Million US$)
...

About Us: QYResearchReports delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.

Contact Us:
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-618-1030
Web: http://www.qyresearchreports.com
Email: sales@qyresearchreports.com

This release was published on openPR.